The objective of this study is to determine the safe use and tolerance of a peptide-based formula in children with gastrointestinal dysfunction and/or feeding intolerance.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
27
Sole source nutrition as per HCP
University of Alberta, Stollery Children's Hospital
Edmonton, Alberta, Canada
Stool frequency
Time frame: 14 Days
Frequency and intensity of irritability, vomiting, distension
Time frame: 14 Days
Average Energy Intake
Time frame: 14 Days
Anthropometrics
Time frame: 14 Days
Medication Use
Time frame: 14 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.